Figure 3. Retrospective complication rates for SurgiMend®, Epiflex® and Tutomesh®. SurgiMend® data have been pooled with (10) in order to increase the number of samples (n). Epiflex® data was also first presented in (10). Tutomesh® data was collected in this trial only.
